FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine
April 27, 2020Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine
The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …
European Medicines Agency’s review of Picato finds its risks outweigh its benefits
April 24, 2020Business Services, Medical Communications, Sales and Marketing
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …
Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial
April 24, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …
Top Ten most popular articles on Pharmafile.com this week
April 24, 2020Medical Communications COVID-19, coronavirus, top 10
Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …
European countries wary about confronting China over COVID-19 death figures
April 24, 2020Medical Communications COVID-19, China, coronavirus
National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European …
Trump widely criticised for suggesting patients could receive injections of disinfectant as COVID-19 cure
April 24, 2020Medical Communications COVID-19, coronavirus
President Donald Trump stunned the medical community by suggesting disinfectant and UV light could be used to treat patients suffering …
Socially disruptive measures will exist in Britain until at least the end of the year
April 23, 2020Business Services Britian COVID-19, COVID-19, coronavirus
England’s Chief Medical Officer Chris Whitty has said that the UK will have to live with some form of socially …
FDA approves Immunomedics’ Trodelvy for metastatic triple-negative breast cancer one month ahead of schedule
April 23, 2020Sales and Marketing Cancer, Immunomedics, Trodelvy, breast cancer, pharma
Immunomedics has scored approval with the FDA for Trodelvy (sacituzumab govitecan-hziy) in the treatment of metastatic triple-negative breast cancer, it …
Cheaper Canadian drug imports continue to be seized by the FDA
April 23, 2020Business Services COVID-19, Canada, FDA, coronavirus, insulin
Seizures of Canadian drugs being sent to American patients have been stepped up by the FDA. This is according to …
Novartis’ Jakavi Phase 3 trial is first of its kind to hit main goal in steroid-refractory acute graft-versus-host disease
April 23, 2020Research and Development Jakavi, Novartis, pharrma
Novartis has revealed impactful new Phase 3 data for its therapy Jakavi (ruxolitinib) in the treatment of patients with steroid-refractory …
BARDA director abruptly leaves post, claims he was ousted over pushback to hydroxychloroquine
April 23, 2020Business Services COVID-19, HHS, coronavirus
Rick Bright has claimed that he has been forced out of his position as the Director of the US Biomedical …
Boehringer’s nintedanib approved in Europe for systemic sclerosis-associated interstitial lung disease
April 22, 2020Research and Development, Sales and Marketing Boehringer Ingelheim, EU, nintedanib, pharma
The European Commission has moved to authorise Boehringer Ingelheim’s nintedanib in Europe for the treatment of systemic sclerosis-associated interstitial lung …
Pharmafile.com’s weekly COVID-19 news round-up
April 22, 2020Research and Development COVID-19, coronavirus, hydroxychloroquine
Hydroxychloroquine has faced setbacks as a potential COVID-19 treatment, as it failed a clinical trial in France and a study …
First in-home COVID-19 testing kit approved by the FDA
April 22, 2020Research and Development COVID-19, Testing kits, coronavirus, testing swabs
The US Food and Drug Administration have granted emergency clearance to the first in-home COVID-19 testing kit. The nasal swab …
AbbVie’s Imbruvica scoops up 11th FDA approval with chronic lymphocytic leukaemia/small lymphocytic lymphoma nod
April 22, 2020Research and Development, Sales and Marketing Cancer, FDA, imbruvica, leukaemia
AbbVie’s Imbruvica (ibrutinib) has scored its 11th FDA approval, this time in combination with rituximab for the treatment of chronic …
National Institutes of Health says COVID-19 patients should not take hydroxychloroquine
April 22, 2020Research and Development COVID-19, coronavirus, hydroxychloroquine
Experts at the US National Institutes of Health (NIH) have drafted treatment guidelines for the use of hydroxychloroquine in COVID-19 …
Bayer’s Vitrakvi becomes first tumour-agnostic therapy approved by NICE for NHS patients with NTRK fusion+ cancer
April 21, 2020Manufacturing and Production, Sales and Marketing Bayer, Cancer, NICE, UK, Vitrakvi, tumour agnostic
Bayer’s oral TRK inhibitor Vitrakvi (larotrectinib) has just been recommended by NICE in the treatment of advanced neurotrophic tyrosine receptor …
Deaths in England and Wales hit 20 year high due to COVID-19 fatalities
April 21, 2020Manufacturing and Production COVID-19, COVID-19 UK, coronavirus, coronavirus uk
Deaths in England and Wales have hit a 20 year high, boosted by fatalities from the COVID-19 coronavirus. The Office …
Phase 3 kidney cancer trial of Bristol Myers Squibb’s Opdivo and Exelixis’ Cabometyx meets primary endpoint
April 21, 2020Manufacturing and Production BMS, Bristol-Myers Squibb, Exelixis, bristol myers squibb
Bristol Myers Squibb and Exelixis have announced that the Phase 3 trial investigating the combination of Opdivo (nivolumab) and Cabometyx …
Five-year data supports early treatment with Novartis’ Mayzent in secondary progressive multiple sclerosis
April 21, 2020Manufacturing and Production, Research and Development Mayzent, Novartis, pharma
Novartis has pulled back the curtain on five-year data from an extension trial for its sphingosine 1-phosphate receptor modulator Mayzent …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
